Rapport Therapeutics prices $250M stock at $26 per share Rapport Therapeutics prices $250M stock at $26 per share Post ContentrappRead More You might also be interested in reading How Israeli VCs Are Doubling Down on DeFi Startups. September 10, 2025 In Mainstream ← Previous post Next post →